209 related articles for article (PubMed ID: 23648139)
21. Downregulation of HDPR1 is associated with poor prognosis and affects expression levels of p120-catenin and beta-catenin in nonsmall cell lung cancer.
Yang ZQ; Zhao Y; Liu Y; Zhang JY; Zhang S; Jiang GY; Zhang PX; Yang LH; Liu D; Li QC; Wang EH
Mol Carcinog; 2010 May; 49(5):508-19. PubMed ID: 20232357
[TBL] [Abstract][Full Text] [Related]
22. Alteration of the E-cadherin/β-catenin complex predicts poor response to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment.
Yoo SB; Kim YJ; Kim H; Jin Y; Sun PL; Jheon S; Lee JS; Chung JH
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S545-52. PubMed ID: 23579873
[TBL] [Abstract][Full Text] [Related]
23. Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators.
Kotsinas A; Evangelou K; Zacharatos P; Kittas C; Gorgoulis VG
Am J Pathol; 2002 Nov; 161(5):1619-34. PubMed ID: 12414510
[TBL] [Abstract][Full Text] [Related]
24. DDX17 nucleocytoplasmic shuttling promotes acquired gefitinib resistance in non-small cell lung cancer cells via activation of β-catenin.
Li K; Mo C; Gong D; Chen Y; Huang Z; Li Y; Zhang J; Huang L; Li Y; Fuller-Pace FV; Lin P; Wei Y
Cancer Lett; 2017 Aug; 400():194-202. PubMed ID: 28259822
[TBL] [Abstract][Full Text] [Related]
25. The expression of estrogen receptors β2, 5 identifies and is associated with prognosis in non-small cell lung cancer.
Liu Z; Liao Y; Tang H; Chen G
Endocrine; 2013 Oct; 44(2):517-24. PubMed ID: 23475473
[TBL] [Abstract][Full Text] [Related]
26. PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness.
Chen MJ; Wu DW; Wang YC; Chen CY; Lee H
Sci Rep; 2016 Oct; 6():34933. PubMed ID: 27713506
[TBL] [Abstract][Full Text] [Related]
27. [Expressions of Axin and beta-catenin in non-small cell lung cancer].
Xu HT; Wang L; Lin D; Liu Y; Liu N; Wang EH
Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):519-23. PubMed ID: 16383300
[TBL] [Abstract][Full Text] [Related]
28. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
29. Expression of p130cas, E-cadherin and β-catenin and their correlation with clinicopathological parameters in non-small cell lung cancer: p130cas over-expression predicts poor prognosis.
Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Han Y; Liu Y; Wang E
Folia Histochem Cytobiol; 2012 Oct; 50(3):392-7. PubMed ID: 23042269
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.
Cox G; Jones JL; O'Byrne KJ
Clin Cancer Res; 2000 Jun; 6(6):2349-55. PubMed ID: 10873086
[TBL] [Abstract][Full Text] [Related]
31. Dishevelled family proteins are expressed in non-small cell lung cancer and function differentially on tumor progression.
Wei Q; Zhao Y; Yang ZQ; Dong QZ; Dong XJ; Han Y; Zhao C; Wang EH
Lung Cancer; 2008 Nov; 62(2):181-92. PubMed ID: 18692936
[TBL] [Abstract][Full Text] [Related]
32. [Subcellular localization of survivin in non-small cell lung cancer].
He L; Hou M; Zhang J; Xu N; Chen P
Ai Zheng; 2009 Sep; 28(9):955-60. PubMed ID: 19728914
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer.
Schläfli AM; Adams O; Galván JA; Gugger M; Savic S; Bubendorf L; Schmid RA; Becker KF; Tschan MP; Langer R; Berezowska S
Oncotarget; 2016 Jun; 7(26):39544-39555. PubMed ID: 27250032
[TBL] [Abstract][Full Text] [Related]
34. Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.
Fukuoka J; Fujii T; Shih JH; Dracheva T; Meerzaman D; Player A; Hong K; Settnek S; Gupta A; Buetow K; Hewitt S; Travis WD; Jen J
Clin Cancer Res; 2004 Jul; 10(13):4314-24. PubMed ID: 15240517
[TBL] [Abstract][Full Text] [Related]
35. 1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells.
Jia Z; Zhang Y; Yan A; Wang M; Han Q; Wang K; Wang J; Qiao C; Pan Z; Chen C; Hu D; Ding X
Cell Death Dis; 2020 Aug; 11(8):670. PubMed ID: 32820157
[TBL] [Abstract][Full Text] [Related]
36. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
[TBL] [Abstract][Full Text] [Related]
37. Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas.
Bleckmann A; Siam L; Klemm F; Rietkötter E; Wegner C; Kramer F; Beissbarth T; Binder C; Stadelmann C; Pukrop T
Clin Exp Metastasis; 2013 Apr; 30(4):471-82. PubMed ID: 23224985
[TBL] [Abstract][Full Text] [Related]
38. Beta-catenin expression is prognostic of improved non-small cell lung cancer survival.
Chiu CG; Chan SK; Fang ZA; Masoudi H; Wood-Baker R; Jones SJM; Gilks B; Laskin J; Wiseman SM
Am J Surg; 2012 May; 203(5):654-659. PubMed ID: 22402266
[TBL] [Abstract][Full Text] [Related]
39. Stomatin-like protein 2 regulates survivin expression in non-small cell lung cancer cells through β-catenin signaling pathway.
Yang CT; Li JM; Li LF; Ko YS; Chen JT
Cell Death Dis; 2018 Apr; 9(4):425. PubMed ID: 29556045
[TBL] [Abstract][Full Text] [Related]
40. Membranous expression of activated leukocyte cell adhesion molecule contributes to poor prognosis and malignant phenotypes of non-small-cell lung cancer.
Ishiguro F; Murakami H; Mizuno T; Fujii M; Kondo Y; Usami N; Taniguchi T; Yokoi K; Osada H; Sekido Y
J Surg Res; 2013 Jan; 179(1):24-32. PubMed ID: 22985775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
